Stock Analysis on Net

Merck & Co. Inc. (NYSE:MRK)

Balance Sheet: Assets

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.

Merck & Co. Inc., consolidated balance sheet: assets

US$ in millions

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Cash and cash equivalents 6,841 12,694 8,096 8,062 9,676
Short-term investments 252 498 774
Accounts receivable, net of allowance for doubtful accounts 10,349 9,450 9,230 7,851 6,778
Inventories, excludes inventories classified in Other assets 6,358 5,911 5,953 6,310 5,978
Other current assets 8,368 7,169 6,987 5,541 4,277
Current assets 32,168 35,722 30,266 27,764 27,483
Investments 252 1,015 370 785 1,469
Property, plant and equipment, at cost, net of accumulated depreciation 23,051 21,422 19,279 17,986 15,053
Goodwill 21,197 21,204 21,264 20,238 19,425
Other intangibles, net 18,011 20,269 22,933 14,604 14,196
Other assets 11,996 9,528 11,582 10,211 6,771
Noncurrent assets 74,507 73,438 75,428 63,824 56,914
Total assets 106,675 109,160 105,694 91,588 84,397

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).


Assets: Selected Items

Balance sheet item Description The company
Current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Merck & Co. Inc. current assets increased from 2021 to 2022 but then slightly decreased from 2022 to 2023 not reaching 2021 level.
Property, plant and equipment, at cost, net of accumulated depreciation Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. Merck & Co. Inc. property, plant and equipment, at cost, net of accumulated depreciation increased from 2021 to 2022 and from 2022 to 2023.
Noncurrent assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. Merck & Co. Inc. noncurrent assets decreased from 2021 to 2022 but then increased from 2022 to 2023 not reaching 2021 level.
Total assets Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Merck & Co. Inc. total assets increased from 2021 to 2022 but then slightly decreased from 2022 to 2023 not reaching 2021 level.

Current Assets: Selected Items

Balance sheet item Description The company
Cash and cash equivalents Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Merck & Co. Inc. cash and cash equivalents increased from 2021 to 2022 but then decreased significantly from 2022 to 2023.
Short-term investments Amount of investment in marketable security, classified as current. Merck & Co. Inc. short-term investments increased from 2021 to 2022 but then slightly decreased from 2022 to 2023.
Accounts receivable, net of allowance for doubtful accounts Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection. Merck & Co. Inc. accounts receivable, net of allowance for doubtful accounts increased from 2021 to 2022 and from 2022 to 2023.
Inventories, excludes inventories classified in Other assets Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. Merck & Co. Inc. inventories, excludes inventories classified in Other assets decreased from 2021 to 2022 but then increased from 2022 to 2023 exceeding 2021 level.